Back to Search
Start Over
Health Canada has approved TALTZ(r) (ixekizumab) for the Treatment of Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)
- Source :
- Plus Company Updates. February 13, 2020
- Publication Year :
- 2020
-
Abstract
- CANADA: Eli Lilly Canada has issued the following press release: Eli Lilly Canada announced today that Health Canada approved TALTZ(r) (ixekizumab) on February 4, 2020, for the treatment of adult [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.614973468